EAJAIC
Eurasian Journal of Anesthesiology and Intensive Care

The Eurasian Journal of Anesthesiology and Intensive Care (EAJAIC) is an independent-unbiased, peer-reviewed, "double-blind", and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, differential diagnoses, editorial opinions, letters to the editor, and educational papers in anesthesiology, algology, and intensive care medicine.

ISSN: Active
eISSN: 3023-6738
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Malign hyperthermia in beating heart coronary artery bypass surgery
Abstract
Malignant hyperthermia (MH) is a rare but one of the most serious complications of general anesthesia due to the hypermetabolic state of skeletal muscle. In this case, it was aimed to share the diagnosis and treatment of the patient who was diagnosed with MH intraoperatively during cardiac surgery. Consent was obtained from the 59-year-old patient who was scheduled for CABGx2 surgery on his beating heart. The patient had no comorbidities other than hypertension. He was a non-smoker and had no history of previous surgery. Hypermetabolic findings began in the 90th minute of the operation. Body temperature: 39°C; pCO2: 72 mmHg; pH: 7.15; potassium was 5.13 mEq/L and pulse was >120.min-1. MH was considered when the color change in soda lime started. After these findings, anesthesia was maintained with 100% oxygen and TIVA anesthesia. The patient, whose hemodynamic stabilization was achieved, was taken to the intensive care unit (ICU) in an intubated state at the end of the surgery. A single dose of 2.5 mg/kg iv dantrolene was administered in the ICU. After dantrolene, body temperature, hemodynamic and metabolic values returned to normal. The patient was extubated on the first postoperative day. The patient, who was followed up in the ICU for 2 days and in the ward for 5 days, was discharged without complications. Dantrolene is the specific antidote for MH. With early application, the risk of complications and mortality can be reduced. Therefore, attention should be paid to the clinical symptoms of MH, and as soon as MH is suspected, triggering agents should be removed immediately and dantrolene supply and treatment should be provided.

Keywords : Beating heart, coronary artery bypass surgery, malign hyperthermia

Download Article


1. Toyota Y, Kondo T, Shorin D, et al. Rapid dantrolene administrationwith body temperature monitoring is associated with decreasedmortality in japanese malignant hyperthermia events. Biomed Res Int.2023;22(23):8340209. doi: 10.1155/2023/8340209
2. Gupta P, Hopkins PM. Diagnosis and management of malignanthyperthermia. BJA Education. 2017;17(7):249-254. doi: 10.1093/bjaed/mkw079
3. Riazi S, Kraeva N, Hopkins PM. Updated guide for the managementof malignant hyperthermia. Can J Anaesth. 2018;65(6):709-721. doi:10.1007/s12630-018-1108-0
4. Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N.Malignant hyperthermia in Canada: characteristics of index anestheticsin 129 malignant hyperthermia susceptible probands. Anesth Analg.2014;118(2):381-387. doi: 10.1213/ANE.0b013e3182937d8b
5. Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinicalpresentation, treatment, and complications of malignant hyperthermiain North America from 1987 to 2006. Anesth Analg. 2010;110(2):498-507. doi: 10.1213/ANE.0b013e3181c6b9b2
6. Glahn KPE, Bendixen D, Girard T, et al. Availability of dantrolene forthe management of malignant hyperthermia crises: european malignanthyperthermia group guidelines. Br J Anaesth. 2020;125(2):133-140.
7. Hopkins PM. Malignant hyperthermia: advances in clinicalmanagement and diagnosis. Br J Anaesth. 2000;85(1):118-128.
8. Rüffert H, Bastian B, Bendixen D, et al. Consensus guidelines onperioperative management of malignant hyperthermia suspectedor susceptible patients from the European Malignant hyperthermiagroup. Br J Anaesth. 2021;126(1):120-130. doi: 10.1016/j.bja.2020.09.029
Article available in :
Volume 1, Issue 3, 2024
Page : 71-73
https://doi.org/10.51271/EAJAIC-0015
Article Information
Received : 18 Tem 2024
Accepted : 26 Tem 2024
Published : 06 Ağu 2024
Corresponding Author :

Emine Nilgün Zengin: Department of Anesthesiology and Reanimation, Ankara Bilkent City Hospital, Ankara, Turkiye

[email protected]
Citation : Zengin H, Zengin EN, Salman N, Şekerci S. Malign hyperthermia in beating heart coronary artery bypass surgery. Eur J Anesthesiol Intensive Care. 2024;1(3):71-73.

Read: 256
Cited: 0
Download : 97
_Footer